
Abbott Laboratories ABT
Annual report 2025
added 02-20-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.74 B |
Market Cap[1] |
$ 178 B |
EBITDA (LTM) |
$ 8.77 B |
P/E (LTM) |
29.57 |
P/S (LTM) |
4.19 |
EPS (LTM) |
3.46 |
Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.
Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.
Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.
Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Bruker Corporation
BRKR
|
$ 36.74 | - | $ 5.47 K | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 9.38 | - | $ 266 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.59 | - | $ 36.7 M | Nasdaq Capital Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.07 | - | $ 1.63 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Delcath Systems
DCTH
|
$ 9.7 | - | $ 347 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.45 | 1.77 % | $ 129 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Edwards Lifesciences Corporation
EW
|
$ 81.19 | - | $ 47.5 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.6 | - | $ 122 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 88.6 | - | $ 12 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.9 | - | $ 1.15 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 9.31 | - | $ 717 M | Nasdaq Global Select Market,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 54.14 | - | $ 1.59 B | NYSE,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 1.0 | - | $ 16.9 M | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.63 | - | $ 2.97 B | NYSE,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.94 | - | $ 374 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.89 | -2.81 % | $ 70.4 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Medtronic PLC
MDT
|
$ 86.28 | - | $ 111 B | NYSE,SPB | ||
|
Align Technology
ALGN
|
$ 171.87 | - | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 0.7 | - | $ 29.3 M | NYSE American | ||
|
AxoGen
AXGN
|
$ 32.64 | - | $ 1.5 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Orthofix Medical
OFIX
|
$ 11.77 | - | $ 466 M | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Penumbra
PEN
|
$ 329.87 | - | $ 12.8 B | NYSE,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 203.5 | - | $ 14.3 B | Nasdaq Global Select Market,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.53 | 0.4 % | $ 7.02 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.13 | -0.24 % | $ 874 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Smith & Nephew plc
SNN
|
$ 32.63 | - | $ 23.8 B | NYSE | ||
|
Stryker Corporation
SYK
|
$ 332.3 | - | $ 127 B | NYSE,SPB | ||
|
Tactile Systems Technology
TCMD
|
$ 24.57 | - | $ 562 M | Nasdaq Global Select Market,SPB | ||
|
TELA Bio
TELA
|
$ 0.63 | 5.47 % | $ 29.6 M | Nasdaq Global Select Market | ||
|
TransMedics Group
TMDX
|
$ 104.8 | - | $ 3.56 B | Nasdaq Global Market | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.17 | - | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.